{"filing":{"accession_number":"0001437749-26-018106","cik":"0001401040","ticker":"DMAC","company_name":"DiaMedica Therapeutics Inc.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"dmtp20260520_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774926018106/dmtp20260520_8k.htm"},"events":[{"id":9502,"run_id":8335,"accession_number":"0001437749-26-018106","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from DiaMedica's 2026 Annual General Meeting held on May 20, 2026, filed under Item 5.07. The filing presents final voting tallies for four proposals: director elections, auditor ratification, advisory executive compensation approval, and an omnibus incentive plan amendment. All proposals passed, and the detailed vote counts are material to investors assessing board composition, audit oversight, and equity dilution.","company_name":"DiaMedica Therapeutics Inc.","ticker":"DMAC","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":1156,"accession_number":"0001437749-26-018106","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from DiaMedica's 2026 Annual General Meeting held on May 20, 2026, filed under Item 5.07. The filing presents final voting tallies for four proposals: director elections, auditor ratification, advisory executive compensation approval, and an omnibus incentive plan amendment. All proposals passed, and the detailed vote counts are material to investors assessing board composition, audit oversight, and equity dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:00:23.090151+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1156,"accession_number":"0001437749-26-018106","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from DiaMedica's 2026 Annual General Meeting held on May 20, 2026, filed under Item 5.07. The filing presents final voting tallies for four proposals: director elections, auditor ratification, advisory executive compensation approval, and an omnibus incentive plan amendment. All proposals passed, and the detailed vote counts are material to investors assessing board composition, audit oversight, and equity dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:00:23.090151+00:00","company_name":"DiaMedica Therapeutics Inc.","ticker":"DMAC","filing_date":"2026-05-21"}]}